Pancreatic cancer pathophysiology: Difference between revisions
Sergekorjian (talk | contribs) |
No edit summary |
||
Line 15: | Line 15: | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
[[Category:Mature chapter]] | [[Category:Mature chapter]] | ||
[[Category:Primary care]] | [[Category:Primary care]] |
Revision as of 14:21, 27 August 2015
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]
Pancreatic cancer Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Pancreatic cancer pathophysiology On the Web |
American Roentgen Ray Society Images of Pancreatic cancer pathophysiology |
Risk calculators and risk factors for Pancreatic cancer pathophysiology |
Overview
The pathophysiology of pancreatic adenocarcinoma includes considerable desmoplasia or formation of a dense fibrous stroma or structural tissue consisting of a range of cell types (including myofibroblasts, macrophages, lymphocytes and mast cells) and deposited material (such as type I collagen and hyaluronic acid).
Pathophysiology
Pathology
The most common form of pancreatic cancer (adenocarcinoma) is typically characterized by moderately to poorly differentiated glandular structures on microscopic examination. There is typically considerable desmoplasia or formation of a dense fibrous stroma or structural tissue consisting of a range of cell types (including myofibroblasts, macrophages, lymphocytes and mast cells) and deposited material (such as type I collagen and hyaluronic acid).